The Developmental Biology of Melanocytes and Its Application to Understanding Human Congenital Disorders of Pigmentation

Advances in Dermatology

Volumn 22, Issue , 2006, Pages 201-218

  Hornyak, Thomas J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CYTOLOGY; GENETICS; HUMAN; MELANOCYTE; MOUSE; MUTATION; NEURAL CREST; PATHOPHYSIOLOGY; PHYSIOLOGY; PIEBALDISM; PIGMENT DISORDER; PRENATAL DEVELOPMENT; REVIEW; WAARDENBURG SYNDROME;

ANIMALS; HUMANS; MELANOCYTES; MICE; MUTATION; NEURAL CREST; PIEBALDISM; PIGMENTATION DISORDERS; WAARDENBURG'S SYNDROME;

EID: 33845626688     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2006.09.002     Document Type: Review

References (67)

1. Lang D., Brown C.B., and Epstein J.A. Neural crest formation and craniofacial development. In: Epstein J., Robert P., Erickson A., et al. (Eds). Inborn errors of development: the molecular basis of clinical disorders of morphogenesis (2004), Oxford, New York 67-74
2. Le Douarin N., and Kalcheim C. The neural crest (1999), Cambridge University Press, Cambridge (UK)
3. Erickson C.A., and Weston J.A. An SEM analysis of neural crest migration in the mouse. J Embryol Exp Morphol 74 (1983) 97-118
4. Weston J.A. Lineage commitment and fate of neural crest-derived neurogenic cells. Adv Pharmacol 42 (1998) 887-891
5. Anderson D.J. Lineages and transcription factors in the specification of vertebrate primary sensory neurons. Trends Genet 13 (1997) 276-280
6. Bronner-Fraser M. Crest destiny. Curr Biol 3 (1993) 201-203
7. Stemple D.L., and Anderson D.J. Isolation of a mammalian neural crest stem cell. Cell 71 (1992) 973-985
8. Ciment G. The melanocyte Schwann cell progenitor: a bipotent intermediate in the neural crest lineage. Comments Developmental Neurobiology 1 (1990) 207-223
9. Hodgkinson C.A., Moore K.J., Nakayama A., et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74 (1993) 395-404
10. Opdecamp K., Nakayama A., Nguyen M.-T.T., et al. Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 124 (1997) 2377-2386
11. Goulding M.D., Chalepakis G., Deutsch U., et al. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 10 (1991) 1135-1147
12. Britsch S., Goerich D.E., Riethmacher D., et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15 (2001) 66-78
13. Erickson C.A., and Goins T.L. Avian neural crest cells can migrate in the dorsolateral path only if they are specified as melanocytes. Development 121 (1995) 915-924
14. Bondurand N., Pingault V., Goerich D.E., et al. Interaction among SOX10, PAX3, and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 9 (2000) 1907-1917
15. Potterf B., Arnheiter H., and Pavan W.J. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet 107 (2000) 1-6
16. Steingrimsson E., Copeland N.G., and Jenkins N.A. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38 (2004) 365-411
17. Budd P.S., and Jackson I.J. Structure of the mouse tyrosinase-related protein-2/dopachrome tautomerase (Tyrp2/Dct) gene and sequence of two novel slaty alleles. Genomics 29 (1995) 35-43
18. Steel K.P., Davidson D.R., and Jackson I.J. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development 115 (1992) 1111-1119
19. Ludwig A., Rehberg S., and Wegner M. Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett 556 (2004) 236-244
20. Jiao Z., Mollaaghababa R., Pavan W.J., et al. Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf. Pigment Cell Res 17 (2004) 352-362
21. Lang D., Lu M.M., Huang L., et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433 (2005) 884-887
22. Nishimura E.K., Yoshida H., Kunisada T., et al. Regulation of E- and P-Cadherin expression correlated with melanocyte migration and diversification. Dev Biol 215 (1999) 155-166
23. Wehrle-Haller B., and Weston J. Soluble and cell-bound forms of steel factor activity play distinct roles in melanocyte precursor dispersal and survival on the lateral neural crest migration pathway. Development 121 (1995) 731-742
24. Hilding D.A., and Ginzberg R.D. Pigmentation of the stria vascularis. The contribution of neural crest melanocytes. Acta Otolaryngol 84 (1977) 24-37
25. Steel K.P., and Barkway C. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development 107 (1989) 453-463
26. Ando M., and Takeuchi S. Immunological identification of an inward rectifier K+ channel (Kir4.1) in the intermediate cell (melanocyte) of the cochlear stria vascularis of gerbils and rats. Cell Tissue Res 298 (1999) 179-183
27. Marcus D.C., Wu T., Wangemann P., et al. KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol 282 (2002) C403-C407
28. Boissy R.E. Extracutaneous melanocytes. In: James J., Nordlund R., Boissy E., et al. (Eds). The pigmentary system: physiology and pathophysiology (2004), Oxford, New York 59-73
29. Tropepe V., Coles B.L., Chiasson B.J., et al. Retinal stem cells in the adult mammalian eye. Science 287 (2000) 2032-2036
30. Raymond S.M., and Jackson I.J. The retinal pigmented epithelium is required for development and maintenance of the mouse neural retina. Curr Biol 5 (1995) 1286-1295
31. Nakayama A., Nguyen M.-T.T., Chen C.C., et al. Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently. Mech Dev 70 (1998) 155-166
32. Horsford D.J., Nguyen M.T., Sellar G.C., et al. Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity. Development 132 (2005) 177-187
33. Nishimura E.K., Jordan S.A., Oshima H., et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416 (2002) 854-860
34. Nishimura E.K., Granter S.R., and Fisher D.E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307 (2005) 720-724
35. Van Neste D., and Tobin D.J. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron 35 (2004) 193-200
36. Yang J.S., Lavker R.M., and Sun T.T. Upper human hair follicle contains a subpopulation of keratinocytes with superior in vitro proliferative potential. J Invest Dermatol 101 (1993) 652-659
37. Silvers W.K. The coat colors of mice (1979), Springer Verlag, New York
38. Asher Jr. J.H., and Friedman T.B. Mouse and hamster mutants as models for Waardenburg syndromes in humans. J Med Genet 27 (1990) 618-626
39. Hemesath T.J., Steingrímsson E., McGill G., et al. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8 (1994) 2770-2780
40. Weilbaecher K.N., Hershey C.L., Takemoto C.H., et al. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell 8 (2001) 749-758
41. Hemesath T.J., Price E.R., Takemoto C., et al. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391 (1998) 298-301
42. Wu M., Hemesath T.J., Takemoto C.M., et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14 (2000) 301-312
43. Chabot B., Stephenson D.A., Chapman V.M., et al. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335 (1988) 88-89
44. Mouse Genome Database (MGD), Mouse Genome Informatics Web Site, The Jackson Laboratory, Bar Harbor, Maine. Available at: http://www.informatics.jax.org. Accessed April 2006.
45. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67 (1991) 767-774
46. Dickie M.M. New Splotch alleles in the mouse. J Hered 55 (1964) 97-101
47. Hornyak T.J., Hayes D.H., Chiu L.-Y., et al. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech Dev 101 (2001) 47-59
48. Southard-Smith E.M., Kos L., and Pavan W.J. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 18 (1998) 60-64
49. Hosoda K., Hammer R.E., Richardson J.A., et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79 (1994) 1267-1276
50. Baynash A.G., Hosoda K., Giaid A., et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79 (1994) 1277-1285
51. Waardenburg P.J. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet 3 (1951) 195-253
52. Read A. PAX3 and the Waardenburg Syndrome Type 1. In: Charles J., Epstein R., Erickson A., et al. (Eds). Inborn errors of development: the molecular basis of clinical disorders of morphogenesis (2004), Oxford, New York 643-648
53. Read A.P., and Newton V.E. Waardenburg syndrome. J Med Genet 34 (1997) 656-665
54. Newton V.E. Hearing loss and Waardenburg syndrome: implications for genetic counseling. J Laryngol Otol 104 (1990) 97-103
55. Liu X.Z., Newton V.E., and Read A.P. Waardenburg syndrome type 2: phenotypic findings and diagnostic criteria. Am J Med Genet 55 (1995) 95-100
56. Read A.P. Waardenburg syndrome. In: Kitamura K., and Steel K.P. (Eds). Genetics in otorhinolaryngology (2000), Karger, Basel (Switzerland) 32-38
57. Tassabehji M., Newton V.E., and Read A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 8 (1994) 251-255
58. Tassabehji M., Newton V.E., Liu X.Z., et al. The mutational spectrum in Waardenburg syndrome. Hum Mol Genet 4 (1995) 2131-2137
59. Sánchez-Martin M., Rodríguez-Garcia A., Pérez-Losada J., et al. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 11 (2002) 3231-3236
60. wh allele on phenotype of murine mast cells. Blood 12 (1999) 4179-4186
61. Hoth C.F., Milunsky A., Lipsky N., et al. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome Type I (WS-I). Am J Hum Genet 52 (1993) 455-462
62. Maroto M., Reshef R., Münsterberg A.E., et al. Ectopic Pax-3 activated MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89 (1997) 139-148
63. Verheij J.B.G.M., and Hofstra R.M.W. EDNRB, EDN3 SOX10 and the Shah-Waardenburg syndrome. In: Charles J., Epstein R., Erickson A., et al. (Eds). Inborn errors of development: the molecular basis of clinical disorders of morphogenesis (2004), Oxford, New York 440-446
64. Tietz W. A syndrome of deaf-mutism associated with albinism showing dominant autosomal inheritance. Am J Hum Genet 15 (1963) 259-264
65. Steingrímsson E., Moore K.J., Lamoreux M.L., et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 8 (1994) 256-263
66. Giebel L.B., and Spritz R.A. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A 88 (1991) 8696-8699
67. Spritz R.A., and Beighton P. Piebaldism with deafness: molecular evidence for an expanded syndrome. Am J Med Genet 75 (1998) 101-103